You are viewing: Asia Pacific Endoscopic Submucosal Dissection/ESD Market analysis

The Asia Pacific Endoscopic Submucosal Dissection/ESD Market was valued at $231.5 Million in 2025 and projected to reach to $334.7 Million by 2030, representing a compound annual growth rate of 7.7%. The Asia Pacific ESD market is poised for sustained growth through 2030, driven by demographic shifts toward aging populations with higher cancer incidence rates and increasing healthcare expenditure across the region.

Asia Pacific Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Asia Pacific Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • Asia Pacific's growth trajectory reflects increasing adoption of minimally invasive gastrointestinal procedures, driven by rising prevalence of early-stage cancers and polyps across the region.
  • The market in Asia Pacific benefits from improving healthcare infrastructure, growing physician training programs, and expanding reimbursement coverage in key markets including Japan, South Korea, and China. Asia Pacific's ESD market is characterized by strong demand for advanced endoscopic instruments and training platforms, supported by a large patient population and increasing awareness of early cancer detection.
  • The region's 7.7% compound annual growth rate (CAGR) from 2025 to 2030 underscores the accelerating shift toward tissue-preserving surgical alternatives in Asia Pacific.
  • Key drivers include aging demographics, rising healthcare expenditure, and the establishment of specialized endoscopy centers throughout Asia Pacific, positioning the region as a critical growth engine for the global ESD market..

Key Market Statistics

  • CAGR (2025-2030) 7.7% CAGR
  • Market Size, 2025 ~USD 231.5 Million
  • Forecast, 2030 ~USD 334.7 Million
  • Geography Asia Pacific

Asia Pacific Endoscopic Submucosal Dissection/ESD Market Overview

Market Valuation & Growth :

Asia Pacific ESD market valued at USD 231.5 million in 2025, expanding at 7.7% CAGR to reach USD 334.7 million by 2030, outpacing many developed regions.

Japan's Market Leadership :

Japan dominates Asia Pacific with USD 69.3 million market share, driven by advanced healthcare infrastructure, high adoption of minimally invasive techniques, and aging population with increased cancer prevalence.

Rising Cancer Prevalence :

Increasing incidence of early-stage gastrointestinal cancers and polyps across Asia Pacific nations is accelerating demand for ESD procedures as a preferred minimally invasive treatment option.

Emerging Market Opportunities :

China (USD 31.4M) and South Korea (USD 26.7M) present significant growth opportunities due to improving healthcare access, rising disposable incomes, and growing awareness of advanced endoscopic procedures.

Asia Pacific Endoscopic Submucosal Dissection/ESD Market Dynamics

  • Countries like Japan, China, and South Korea are leading adoption due to advanced medical infrastructure and strong reimbursement frameworks.
  • The region's 7.7% CAGR reflects growing physician expertise in ESD techniques and patient preference for minimally invasive alternatives to surgery. Expanding middle-class populations in emerging Asia Pacific economies are driving healthcare modernization and adoption of advanced endoscopic technologies.
  • Government initiatives promoting early cancer detection and preventive care, combined with rising medical tourism, are expected to further accelerate market penetration.
  • Strategic partnerships between international device manufacturers and regional healthcare providers will enhance market accessibility and drive innovation in ESD equipment and training programs..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Asia Pacific ESD market valued at USD 231.5 million in 2025, expanding to USD 334.7 million by 2030 at a 7.7% CAGR
    • Asia Pacific's growth driven by rising early-stage cancer detection, aging populations, and improved healthcare infrastructure across the region
    • Asia Pacific benefits from strong reimbursement expansion and physician training initiatives in Japan, South Korea, and China
    • Asia Pacific represents a critical growth region, with minimally invasive endoscopic procedures gaining rapid adoption over traditional surgical alternatives

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    Asia Pacific Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : Need Asia Pacific-specific market data to develop regional product strategies, identify high-growth countries, and establish distribution networks for ESD equipment and accessories.
    • Healthcare Investors & PE Firms : Require detailed market sizing and growth forecasts for Asia Pacific to evaluate investment opportunities in endoscopy centers, medical device companies, and healthcare infrastructure projects.
    • Hospital & Clinic Operators : Need regional market insights to justify ESD program investments, benchmark adoption rates against competitors, and plan capital expenditure for endoscopy department expansion.
    • Gastroenterology Specialists : Seek market data on ESD adoption trends, training opportunities, and equipment availability across Asia Pacific to enhance clinical practice and patient care offerings.
    • Market Consultants & Analysts : Require comprehensive Asia Pacific ESD market data for client advisory, competitive analysis, and strategic recommendations in the healthcare and medical device sectors.

    Key Companies in the Asia Pacific Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Asia Pacific vs. other regions

    HowAsia Pacific compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 160.7 Million · 8.8% wtd CAGR ·
    Europe
    ~USD 203.1 Million · 9.1% wtd CAGR ·
    Middle East & Africa
    ~USD 11.6 Million · 9.9% wtd CAGR ·
    Latin America
    ~USD 33.4 Million · 8.3% wtd CAGR ·

    Countries within Asia Pacific - compare and drill down

    Country2025 size (native)
    JapanUSD 69.3 Million
    ChinaUSD 31.4 Million
    IndiaUSD 11.2 Million
    South KoreaUSD 26.7 Million
    AustraliaUSD 6.1 Million
    Rest Of Asia PacificUSD 22.4 Million

    Country market size visualization

    Japan
    USD 69.3 Million
    China
    USD 31.4 Million
    India
    USD 11.2 Million
    South Korea
    USD 26.7 Million
    Australia
    USD 6.1 Million
    Rest Of Asia Pacific
    USD 22.4 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Detailed breakdown of Asia Pacific ESD market by country, including Japan (USD 69.3M), China (USD 31.4M), South Korea (USD 26.7M), and India, enabling targeted market entry strategies.
    • Growth Trajectory Analysis : Comprehensive CAGR projections (7.7%) and forecasts through 2030 specific to Asia Pacific, supporting long-term business planning and investment decisions in the region.
    • Competitive Landscape Insights : Understanding of regional market dynamics, key players, and adoption patterns unique to Asia Pacific healthcare systems, regulatory environments, and reimbursement structures.
    • Emerging Market Opportunities : Identification of high-growth markets in China, India, and Southeast Asia with expanding middle-class populations and improving healthcare infrastructure for ESD adoption.
    • Strategic Partnership Data : Market intelligence for identifying distribution partners, healthcare providers, and investment opportunities specific to Asia Pacific's diverse healthcare ecosystems and regulatory requirements.

    Frequently asked questions

    What is the current market size of ESD in Asia Pacific?

    The Asia Pacific ESD market is valued at USD 231.5 million in 2025 and is projected to grow to USD 334.7 million by 2030.

    What is the expected growth rate for Asia Pacific's ESD market?

    Asia Pacific's ESD market is expected to grow at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2030.

    Which countries are driving growth in Asia Pacific's ESD market?

    Key markets in Asia Pacific include Japan, South Korea, and China, where advanced healthcare infrastructure and reimbursement policies support ESD adoption.

    What factors are accelerating ESD adoption in Asia Pacific?

    Asia Pacific's ESD market growth is driven by aging demographics, rising early-stage cancer prevalence, improved healthcare infrastructure, and expanding physician training programs.

    How does Asia Pacific's ESD market compare to global growth?

    Asia Pacific's 7.7% CAGR is slightly below the global 8.4% CAGR, but the region represents a critical growth market due to its large patient population and expanding healthcare systems.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status